Given the crucial role of HMGA1 in conferring TNBC aggressiveness through the modulation of specific gene networks and pathways, we dissected other HMGA1-mediators of cancer cell motility and found a highly significant association with the expression of stathmin protein in BC patients, which was further supported by a clinical correlation of the expression of both genes. This evidence concerns the gene HMGA1 and breast cancer.